anti-FGFR3 scFv antibody fragments (CNIO)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Nameanti-FGFR3 scFv antibody fragments (CNIO)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment
Mechanisms of ActionFibroblast growth factor receptor 3 antagonists
TargetsFibroblast growth factor receptor 3
Therapy Area/IndicationsUrinary Bladder Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCentro Nacional De Investigaciones Oncologicas
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCentro Nacional De Investigaciones Oncologicas
Active IndicationsN/A
Inactive IndicationsUrinary Bladder Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A